The orthobiologics devicemaker, based in Durham, N.C., said it will pay $45 million upfront to acquire Bioness and up to $65 million more, contingent on meeting certain key milestones. It didn’t specify the milestones.
Under the agreement, Bioness will become a wholly owned subsidiary of Bioventus.
Bioventus said the total addressable market for medical devices marketed by Bioness is estimated to be more than $8 billion.
Read the full news release here.
More articles on supply chain:
US pulls 25M isolation gowns from national stockpile over safety concerns
Carcinogen found in 44 hand sanitizer brands introduced during pandemic
How Cardinal Health is using tracking technology to get a better look into its supply chain
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.